Cancer Progress 2025

Cancer Progress is returning as a live, in-person event in New York City!

This streamlined, one-day conference promises a focused and impactful experience. Attendees can expect unparalleled insights, in-depth issue coverage, and exceptional networking opportunities. The conference’s enduring success and value are driven by the expertise and reputation of its distinguished speaking faculty.

Join us for this dynamic gathering of experts for a thought-provoking exploration of the possibilities and challenges inherent in shaping the future of oncology.

100% of proceeds from ticket sales and sponsorships will directly support the Damon Runyon Cancer Research Foundation and its mission to fund high-risk, high-reward cancer research.

Questions? Email us at contact@lumanity.com.

Cancer Progress was started in 1989 with the goal of facilitating discussions of scientific progress within the context of development, regulatory, clinical, commercial and investment perspectives. Cancer Progress has historically featured two to three days of provocative, informative panel discussions with pivotal topics, frank discussions, vigorous debate, opportunities for audience questions and comments, and a partnering platform to enable meaningful connections and meetings with innovators, developers, and investors.

Axel Hoos MD, PhD

Peter Sandor MD, PHD

EVP, Head of Corporate Strategy
Astellas Pharma US

Kapil Dhingra MD

Managing Member
KAPital Consulting LLC

Francesca Barone MD, PhD

Chief Scientific Officer
Candel Therapeutics

John Wiggins

VP, Isotope Strategy Lantheus

Lucy Kappel PhD

Vice President, Head of Oncology Business Development, Regeneron Pharmaceuticals

Ashlee Cramer

Caregiver and advocate for cancer and GvHD, Social Influencer, Michael and Mom Talk Cancer

Michael Cramer

Cancer survivor, Patient advocate for cancer and GvHD, Social Influencer, Michael and Mom Talk Cancer

Dominique Verhelle PhD, MBA

Co-Founder & CEO, NextRNA Therapeutics

Kimberly Richardson

Founder, Black Cancer Collaborative

Joe Guidi

VP, Global Medical Early Differentiation and Pipeline, Bristol Myers Squibb

Dennis Chang

Senior Vice President, Strategy Consulting, Lumanity

Martin Strebl-Bantillo

Principal, Strategy Consulting, Lumanity

Jeff Bockman

Expert Advisor and EVP, Oncology, Strategy Consulting Lumanity

Ed Saltzman

Senior Strategic Advisor, Lumanity

Michael Parisi

Joint Global Practice Lead, Medical Strategy and Communications, Lumanity

Angela Wheeler

President, Insight US, Lumanity

Yung S. Lee PhD

President & CEO, Damon Runyon Research Foundation